Skip to main content

CITADEL ADVISORS LLC

Position in MAZE — Maze Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in MAZE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$25,443,851
+$2,288,789 QoQ
Shares Held
852,676
+9.9% QoQ
Ownership
1.53%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#23
of 161 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MAZE Over Time

Shares Held

Position Value (USD)

Derivatives in MAZE

reported options exposure · as of Jun 30, 2026
CallValue
$375,984
CallShares
12,600
PutValue
$286,464
PutShares
9,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. MAZE ranks #48 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MAZE

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $375,984 12,600
2026-06-30 $25,443,851 852,676
2026-06-30 $286,464 9,600
2026-03-31 $743,265 24,900
2026-03-31 $23,155,062 775,714
2026-03-31 $256,710 8,600
2025-12-31 $18,569,630 448,217
2025-03-31 $220,200 20,000